-
Startseite
-
a-t-Inhaltsverzeichnis
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
 
  NEW ON THE MARKET
 

New drug for gout: febuxostat (ADENURIC)

Prucalopride (RESOLOR) for chronic obstipation

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Bipolar disorder: lithium plus valproic acid?

Cave: Tamoxifen plus CYP 2D6 inhibitors

 
  READERS' QUESTIONS AND COMMENTS
 

Pink rockrose extract CYSTUS 052 against influenza?

XENOBILOX: price rise by a factor of 15

 
  IN BRIEF
 

Ethosuximide (e.g. PETNIDAN) in childhood absence epilepsy

No primary prevention with acetylsalicylic acid

Intensive care: dopamine or noradrenaline for treatment of shock?

Losartan (LORZAAR) generics available

Denture adhesive COREGA ULTRA off market

Trade names likely to be mistaken

 
  CURRENT ADR NETWORK REPORT

Nose bleeds due to alpha receptor blocker tamsulosin

 
  SIDE EFFECTS
 

Bradycardia due to antihistamine fexofenadine

 
© arznei-telegramm 3/2010